{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-016388","form_type":"8-K","ticker":"ZVSA","cik":"0001859007","company_name":"ZyVersa Therapeutics, Inc.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.212956+00:00","generated_at":"2026-05-18T19:57:27.276326+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ZyVersa enters $10M equity purchase agreement with Williamsburg Venture Holdings to fund VAR 200 clinical development","bullets":["Up to $10M of common stock; company controls timing and amount of sales over 24-month term.","Purchase price set at 94% of lowest VWAP during three trading days after each sale clears.","2.5% commitment fee in common shares, with piggyback registration rights; no warrants or derivatives.","Funds intended to progress clinical development of Cholesterol Efflux Mediator TM VAR 200 for chronic kidney disease.","Issuance capped at 19.99% of outstanding shares unless stockholder approval is obtained."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-016388","json":"https://secwatch.observer/filing/0001641172-25-016388.json","markdown":"https://secwatch.observer/filing/0001641172-25-016388.md","text":"https://secwatch.observer/filing/0001641172-25-016388.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859007/000164117225016388/0001641172-25-016388-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859007/000164117225016388/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T19:57:27.276326+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}